248 related articles for article (PubMed ID: 7687858)
1. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells.
Pierelli L; Teofili L; Menichella G; Rumi C; Paoloni A; Iovino S; Puggioni PL; Leone G; Bizzi B
Br J Haematol; 1993 May; 84(1):24-30. PubMed ID: 7687858
[TBL] [Abstract][Full Text] [Related]
2. Predominance of myeloid antigens in CD34-positive peripheral blood stem cells over those in bone marrow after administration of granulocyte colony-stimulating factor.
Fukuda T; Okamura S; Shimoda K; Takamatsu Y; Inaba S; Harada M; Niho Y
Eur J Haematol; 1994 Apr; 52(4):201-6. PubMed ID: 7516293
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
4. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
Verfaillie CM; Miller JS
Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
[TBL] [Abstract][Full Text] [Related]
5. Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.
Litzow MR; Brashem-Stein C; Andrews RG; Bernstein ID
Blood; 1991 Jun; 77(11):2354-9. PubMed ID: 1710150
[TBL] [Abstract][Full Text] [Related]
6. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential.
Muench MO; Cupp J; Polakoff J; Roncarolo MG
Blood; 1994 Jun; 83(11):3170-81. PubMed ID: 7514903
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation.
Bender JG; Unverzagt K; Walker DE; Lee W; Smith S; Williams S; Van Epps DE
Clin Immunol Immunopathol; 1994 Jan; 70(1):10-8. PubMed ID: 7505211
[TBL] [Abstract][Full Text] [Related]
9. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
Rusten LS; Jacobsen SE; Kaalhus O; Veiby OP; Funderud S; Smeland EB
Blood; 1994 Sep; 84(5):1473-81. PubMed ID: 7520773
[TBL] [Abstract][Full Text] [Related]
10. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
[TBL] [Abstract][Full Text] [Related]
11. Comparison of CD34+ subsets and clonogenicity in human bone marrow, granulocyte colony-stimulating factor-mobilized peripheral blood, and cord blood.
Cho SH; Chung IJ; Lee JJ; Park ML; Kim HJ
J Korean Med Sci; 1999 Oct; 14(5):520-5. PubMed ID: 10576147
[TBL] [Abstract][Full Text] [Related]
12. RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression.
Rumi C; Rutella S; Teofili L; Etuk B; Ortu La Barbera E; Micciulli G; Voso MT; Leone G
Exp Hematol; 1997 Mar; 25(3):246-51. PubMed ID: 9091301
[TBL] [Abstract][Full Text] [Related]
13. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients.
D'Arena G; Cascavilla N; Musto P; Greco M; Di Mauro L; Carella AM; Dello Iacono N; Carotenuto M
Haematologica; 1996; 81(3):216-23. PubMed ID: 8767526
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
[TBL] [Abstract][Full Text] [Related]
16. Sequential expression of CD34 and CD33 antigens on myeloid colony-forming cells.
Bühring HJ; Asenbauer B; Katrilaka K; Hummel G; Busch FW
Eur J Haematol; 1989 Feb; 42(2):143-9. PubMed ID: 2465178
[TBL] [Abstract][Full Text] [Related]
17. Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood.
Möhle R; Haas R; Hunstein W
J Hematother; 1993; 2(4):483-9. PubMed ID: 7522108
[TBL] [Abstract][Full Text] [Related]
18. Characterization of peripheral blood CD34+ progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor.
Teofili L; Iovino MS; Sica S; Pierelli L; Menichella G; De Stefano V; Rumi C; Leone G
Exp Hematol; 1994 Sep; 22(10):990-5. PubMed ID: 7522187
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
[TBL] [Abstract][Full Text] [Related]
20. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor.
Siena S; Bregni M; Brando B; Ravagnani F; Bonadonna G; Gianni AM
Blood; 1989 Nov; 74(6):1905-14. PubMed ID: 2478216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
